The "24th World Congress on Pediatric Oncology and Cancer Care" will take place in Frankfurt, Germany, from October 02-03, 2023 centered around the theme on Pediatric Cancer and Oncology: Improving Treatments and Fostering Supports. It will feature keynote speeches, poster presentations, oral lectures, and exhibitions. In order to discuss and learn more about various topics related to Cancer Biomarkers, Anti-Cancer drug discovery therapy, Gynaecologic Oncology, Immuno Oncology, Neuro Oncology, Oncology Nursing, Pediatric Oncology, Pulmonary Oncology, Surgical Oncology, Cancer and Oncology Genetics and further more. There is a worldwide platform known as the Pediatric Cancer Congress. At Pediatric Oncologists 2023, Conference Series has made the first move to bring together bright specialists from both industry and academia on a single platform. Young researchers and students can observe the research on paediatric cancer that is presented at the conference from a variety of scientific backgrounds. The primary goal of Pediatric Cancer Congress 2023 is to disseminate knowledge in the medical and life sciences that researchers would need in the course of their work. As a result, Germany would be the ideal location for this exchange of information. The Pediatric Cancer Congress 2023 provides a global forum for the presentation of research on cutting-edge methods, ground-breaking devices, and numerous recently introduced drugs for the treatment of paediatric and neonatal oncology. By exchanging ideas on various topics under this subject, the conference contributes to the dissemination of knowledge and lowers the incidence rate globally. Each conference frequently features several speakers, all of whom are experts in oncology-related subjects. Every day during the Pediatric Oncology Congress, a variety of topic analyses are scheduled, and participants often select their own topics from among these global events. The goal of Pediatric Cancer Congress 2023 is to present honorary awards to deserving Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, and junior professors in recognition of their excellent contributions to the conference theme. The Young Scientist Awards strive to offer academicians in their early careers with a solid professional development opportunity by bringing specialists together to exchange and share their expertise on all facets of cancer care and oncology. Young Researchers in Pediatric Cancer Congress Awards for the Nomination in 2023: The Pediatric Cancer Congress 2023 Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation will only accept 20 presentations. Advantages of YRF Registrations: Young Scientist Award recipients get certificates of achievement and souvenirs. For oral presentations of your research, Pediatric Cancer Congress 2023 offers the finest venue. Through networking, you can find out about new technology and employment opportunities. Permit research collaboration with renowned senior researchers from around the globe in the area of nanotechnology. It's a fantastic chance for young researchers to learn about different study fields and increase their research knowledge. Why to attend Pediatric Cancer Congress 2023 is one of the best and most exciting opportunities that have been created in an interdisciplinary approach with a wide range of tracks to present new technology, new goods, and services that your sector may provide to a big global audience. They will have a great opportunity to showcase their most recent work on Pediatric Cancer and Oncology because it covers a wide variety of themes. It anticipates more than 200 attendees from around the world to participate with thought-provoking Keynote lectures, oral presentations, and poster presentations at Pediatric Cancer Congress 2023, which will feature presentations by professionals from around the world in the field of medical, healthcare and oncology fields. Editorial board members from related international publications are represented by the delegates. As a low-cost marketing strategy for generating sales, possibilities, and contacts, business networking gives suppliers the chance to network and meet with "Top Scientists and Colleagues." To encourage students and recent graduates to exhibit their unique research, which will be published in journals later, the student poster competition is held at the conference. Poster sessions at the conference will feature all of the submitted abstracts. Students who are unable to attend the conference can present an E-Poster for just $99, with the abstract being posted online with a DOI. The addition of live streaming is a value-added service for the speaker. Target Audience: Doctors, Young Research Scientists, Medical Colleges, Pediatric Cancer Associations and Societies, Manufacturing Medical Devices Companies, Healthcare Professionals, Directors of healthcare Companies, Leading Scientists, Oncologists, Medicine, and Pharmaceuticals, Fellows or Postdoctoral Students, Researchers, CEOs, and Business Delegates Highlights of the conference: More than 300 participants (70 Industry: 30 Academia) Five keynote speakers or more; 50 or more speakers at the plenary; and Twenty exhibitors or more Five or more workshops; fourteen creative educational sessions; and business meetings The pleasure of attending Pediatric Cancer Congress 2023 entails improvement and gradual evolution in your method of operation, as well as the opportunity to view things in a wider framework and encounter the educational and industrial overviews. Tracks and Sessions Track 1: Oncology Nursing Track 2: Radiation Oncology Track 3: Colorectal Cancer and Stem cells Track 4: Cancer Causes and Diagnosis Track 5: Cancer Biomarkers Track 6: Cancer Therapeutics and Novel Approaches Track 7: Cancer management and preventions Track 8: Gynaecologic Oncology Track 9: Immuno Oncology Track 10: Neuro oncology Track 11: Anti-Cancer drug discovery therapy Track 12: Pediatric Oncology Track 13: Pulmonary oncology Track 14: Surgical Oncology Track 15: Cancer and Oncology Diagnosis and Screening Track 16: Cancer and Oncology Genetics Track 17: Cancer awareness and survival Track 18: Cancer Epidemiology Preventions Track 19: Cancer Metastasis Track 20: Clinical Oncology Track 21: Natural methods for treatment of cancer Track 22: Neonatal and Pediatric Oncology Track 23: Oncology and Cancer Research Track 24: Pediatric Pharmacotherapy Market Analysis The medical specialty focuses on the detection and management of cancer in children, babies, and teenagers know as pediatric cancer. The DNA of cells can change before birth, which can lead to childhood cancers. According to the most distinct analysis by Emergen Research, the size of the worldwide pediatric oncology market was USD 37.22 billion in 2021 and is anticipated to grow at revenue CAGR (Compound Annual Growth Rate) of 9.5% during the projected period. Pediatric Cancer: Its Aspects and Relevance The medical specialties are pediatrics which covers the medical care for children, teenagers, and newborns. Children's bodies are more sensitive to disease and infection than teens' bodies are. Surgery, chemotherapy, immunotherapy, radiation therapy, and germ/stem cell transplant are common forms of treatment. In order for new ideas or new research to be discussed at the conference and be helpful to children with cancer disorders, we anticipate the experienced global gathering at the neonatal and pediatric centres. According to the most distinct analysis by Emergen Research, the size of the worldwide pediatric oncology market was USD 37.22 billion in 2021 and is anticipated to grow at revenue CAGR (Compound Annual Growth Rate) of 9.5% during the projected period. Market Overview The development of novel technologies and biomarkers to detect early neoplastic indicators in children receiving therapy for acute lymphocytic leukaemia (ALL) is expected to take place within the next five to ten years. On the global market, advancements in tumour treatment are quickly expanding. The focus of the current report is the entire onco diagnostics showcase for the envisioned period from 2015 to 2020. In 2013 and 2014, the global pediatric market was worth $80.7 billion and $83.6 billion, respectively. In 2019, it is anticipated to reach about $100 billion. The term "childhood cancer" refers to cancers that affect children and young adults (those under the age of 15). Depending on the type and stage of the disease, there are numerous efficient cancer therapy options accessible today. Although the majority of cases of juvenile cancer are unknown, it is thought that hereditary mutations are responsible for 5% of all paediatric cancers. The considerable advancement in the area of improvement highlighted by an onco diagnostic broadcast, the general risk diagnostics stage will quickly bring about a change. These tests on new or old drugs to the development of a new generation of clinical trials to treat disease and lessen the toxicity. The various strategies to prevent and remediate cancer harm will emerge and mature at a great pace. The primary factors driving the growth of the pediatric oncology market's revenue are the rise in childhood obesity globally, the prevalence of childhood cancer, the increase in public awareness of cancer therapies, and increased R&D expenditure by pharmaceutical companies. Key Drivers, Restrains, and Opportunities of Global Pediatric Oncology Market The main drivers of the growth of the global market for pediatric oncology treatments are the rise in cancer prevalence, the attractive reimbursement environment, and health care reforms. According to WHO statistics from 2018, cancer is the primary cause of death for kids and teenagers worldwide; each year, almost 300,000 kids between the ages of 3 and 19 are given a cancer diagnosis. Additionally, the WHO established the Global Initiative for Youth Cancers in 2018 with a number of partners to offer effective childhood cancer programmes around the globe. WHO predicted that by the end of 2021, 4, 00,000 children and teenagers globally, aged 3 to 19 would receive a cancer diagnosis in each year. Additionally, in developed nations, there have been widespread introductions of programmes to raise awareness about pediatric cancer, and government investments to improve the pediatric healthcare system have increased. In turn, these variables will fuel market expansion in the ensuing years. The market is anticipated to grow quickly over the next years as more new medicines are released and more cutting-edge cancer treatments are created by pharmaceutical companies. Global Pediatric Oncology Market: Segmentation Based on indication, treatment, end-user, and location, the global market for pediatric oncology treatments can be divided. Leukaemia, bone tumours, brain malignancies, retinoblastoma, lymphoma, and other indications comprise the global market. The vast majority of childhood malignancies are leukaemia-related. Given that, it is the most prevalent cancer in children, the category is expected to dominate the market over the projection period. Chemotherapy, radiation, tumour surgery, and bone marrow transplantation are the different types of treatments available in the global pediatric oncology treatment market. Growing public awareness of cancer treatment options, investment in R&D, and an increase in the prevalence of children cancers like neuroblastoma are all factors - driving market expansion. According to research conducted by the National Cancer Institute in February 2022, there will be one case of neuroblastoma for every 7000 infants. In Each year, 10.54 out of every 1,000,000 children under the age of 15 are diagnosed with this disease. Global Pediatric Oncology Market- By Indication Leukaemia Bone Tumors Brain Cancers Retinoblastoma Global Pediatric Oncology Market- By Treatment Chemotherapy Radiotherapy Tumor Surgery Blood & Marrow Transplantation Global Pediatric Oncology Market- By End-user Hospitals Specialty Clinics Cancer & Radiation Therapy Centres Pediatric Oncology Treatment Market: Competitive Landscape Important Market Participants in the Pediatric Oncology Treatment Sector The existence of a significant number of prominent competitors leads to expansion of the pediatric oncology treatments globally and therefore, is extremely fragmented. The market for pediatric oncology treatments is projected to be driven by growth strategies used by major competitors. The following companies are major players in the global market for paediatric oncology treatments: St. Jude Children's Research Hospitals, Royal Children's Hospital Birmingham Children's and Women's Child Health and Development National Center The St. Louis Children's Hospitals and the Vanderbilt University Medical Center Health SSM and other notable participants Global Pediatric Oncology Market- By Region North America: U.S.A and Canada Europe: Germany, France, U.K., Italy Asia Pacific: China, Japan, India Latin America: Brazil, Mexico Middle East and Africa: South Africa, Rest of Middle East and Africa Contact: Andre Sarria | Conference Manager Pediatric Cancer Congress 2023 WhatsApp: +44 7915648218 Email: pediatriconcology@meetingsemail.com

The "24th World Congress on Pediatric Oncology and Cancer Care" will take place in Frankfurt, Germany, from October 02-03, 2023 centered around the theme on Pediatric Cancer and Oncology: Improving Treatments and Fostering Supports. It will feature keynote speeches, poster presentations, oral lectures, and exhibitions. In order to discuss and learn more about various topics related to Cancer Biomarkers, Anti-Cancer drug discovery therapy, Gynaecologic Oncology, Immuno Oncology, Neuro Oncology, Oncology Nursing, Pediatric Oncology, Pulmonary Oncology, Surgical Oncology, Cancer and Oncology Genetics and further more. There is a worldwide platform known as the Pediatric Cancer Congress. At Pediatric Oncologists 2023, Conference Series has made the first move to bring together bright specialists from both industry and academia on a single platform. Young researchers and students can observe the research on paediatric cancer that is presented at the conference from a variety of scientific backgrounds. The primary goal of Pediatric Cancer Congress 2023 is to disseminate knowledge in the medical and life sciences that researchers would need in the course of their work. As a result, Germany would be the ideal location for this exchange of information. The Pediatric Cancer Congress 2023 provides a global forum for the presentation of research on cutting-edge methods, ground-breaking devices, and numerous recently introduced drugs for the treatment of paediatric and neonatal oncology. By exchanging ideas on various topics under this subject, the conference contributes to the dissemination of knowledge and lowers the incidence rate globally. Each conference frequently features several speakers, all of whom are experts in oncology-related subjects. Every day during the Pediatric Oncology Congress, a variety of topic analyses are scheduled, and participants often select their own topics from among these global events. The goal of Pediatric Cancer Congress 2023 is to present honorary awards to deserving Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, and junior professors in recognition of their excellent contributions to the conference theme. The Young Scientist Awards strive to offer academicians in their early careers with a solid professional development opportunity by bringing specialists together to exchange and share their expertise on all facets of nanotechnology. Young Researchers in Pediatric Cancer Congress Awards for the Nomination in 2023: The Pediatric Cancer Congress 2023 Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation will only accept 20 presentations. Advantages of YRF Registrations: Young Scientist Award recipients get certificates of achievement and souvenirs. For oral presentations of your research, Pediatric Cancer Congress 2023 offers the finest venue. Through networking, you can find out about new technology and employment opportunities. Permit research collaboration with renowned senior researchers from around the globe in the area of nanotechnology. It's a fantastic chance for young researchers to learn about different study fields and increase their research knowledge. Why to attend Pediatric Cancer Congress 2023 is one of the best and most exciting opportunities that have been created in an interdisciplinary approach with a wide range of tracks to present new technology, new goods, and services that your sector may provide to a big global audience. They will have a great opportunity to showcase their most recent work on Pediatric Cancer and Oncology because it covers a wide variety of themes. It anticipates more than 200 attendees from around the world to participate with thought-provoking Keynote lectures, oral presentations, and poster presentations at Pediatric Cancer Congress 2023, which will feature presentations by professionals from around the world in the field of medical, healthcare and oncology fields. Editorial board members from related international publications are represented by the delegates. As a low-cost marketing strategy for generating sales, possibilities, and contacts, business networking gives suppliers the chance to network and meet with "Top Scientists and Colleagues." To encourage students and recent graduates to exhibit their unique research, which will be published in journals later, the student poster competition is held at the conference. Poster sessions at the conference will feature all of the submitted abstracts. Students who are unable to attend the conference can present an E-Poster for just $99, with the abstract being posted online with a DOI. The addition of live streaming is a value-added service for the speaker. Target Audience: Doctors, Young Research Scientists, Medical Colleges, Pediatric Cancer Associations and Societies, Manufacturing Medical Devices Companies, Healthcare Professionals, Directors of healthcare Companies, Leading Scientists, Oncologists, Medicine, and Pharmaceuticals, Fellows or Postdoctoral Students, Researchers, CEOs, and Business Delegates Highlights of the conference: More than 300 participants (70 Industry: 30 Academia) Five keynote speakers or more; 50 or more speakers at the plenary; and Twenty exhibitors or more Five or more workshops; fourteen creative educational sessions; and business meetings The pleasure of attending Pediatric Cancer Congress 2023 entails improvement and gradual evolution in your method of operation, as well as the opportunity to view things in a wider framework and encounter the eudctaional and industrial overviews. Tracks and Sessions Track 1: Oncology Nursing Track 2: Radiation Oncology Track 3: Colorectal Cancer and Stem cells Track 4: Cancer Causes and Diagnosis Track 5: Cancer Biomarkers Track 6: Cancer Therapeutics and Novel Approaches Track 7: Cancer management and preventions Track 8: Gynaecologic Oncology Track 9: Immuno Oncology Track 10: Neuro oncology Track 11: Anti-Cancer drug discovery therapy Track 12: Pediatric Oncology Track 13: Pulmonary oncology Track 14: Surgical Oncology Track 15: Cancer and Oncology Diagnosis and Screening Track 16: Cancer and Oncology Genetics Track 17: Cancer awareness and survival Track 18: Cancer Epidemiology Preventions Track 19: Cancer Metastasis Track 20: Clinical Oncology Track 21: Natural methods for treatment of cancer Track 22: Neonatal and Pediatric Oncology Track 23: Oncology and Cancer Research Track 24: Pediatric Pharmacotherapy Market Analysis The medical specialty focuses on the detection and management of cancer in children, babies, and teenagers know as pediatric cancer. The DNA of cells can change before birth, which can lead to childhood cancers. According to the most distinct analysis by Emergen Research, the size of the worldwide pediatric oncology market was USD 37.22 billion in 2021 and is anticipated to grow at revenue CAGR (Compound Annual Growth Rate) of 9.5% during the projected period. Pediatric Cancer: Its Aspects and Relevance The medical specialties are pediatrics which covers the medical care for children, teenagers, and newborns. Children's bodies are more sensitive to disease and infection than teens' bodies are. Surgery, chemotherapy, immunotherapy, radiation therapy, and germ/stem cell transplant are common forms of treatment. In order for new ideas or new research to be discussed at the conference and be helpful to children with cancer disorders, we anticipate the experienced global gathering at the neonatal and pediatric centres. According to the most distinct analysis by Emergen Research, the size of the worldwide pediatric oncology market was USD 37.22 billion in 2021 and is anticipated to grow at revenue CAGR (Compound Annual Growth Rate) of 9.5% during the projected period. Market Overview The development of novel technologies and biomarkers to detect early neoplastic indicators in children receiving therapy for acute lymphocytic leukaemia (ALL) is expected to take place within the next five to ten years. On the global market, advancements in tumour treatment are quickly expanding. The focus of the current report is the entire onco diagnostics showcase for the envisioned period from 2015 to 2020. In 2013 and 2014, the global pediatric market was worth $80.7 billion and $83.6 billion, respectively. In 2019, it is anticipated to reach about $100 billion. The term "childhood cancer" refers to cancers that affect children and young adults (those under the age of 15). Depending on the type and stage of the disease, there are numerous efficient cancer therapy options accessible today. Although the majority of cases of juvenile cancer are unknown, it is thought that hereditary mutations are responsible for 5% of all paediatric cancers. The considerable advancement in the area of improvement highlighted by an onco diagnostic broadcast, the general risk diagnostics stage will quickly bring about a change. These tests on new or old drugs to the development of a new generation of clinical trials to treat disease and lessen the toxicity. The various strategies to prevent and remediate cancer harm will emerge and mature at a great pace. The primary factors driving the growth of the pediatric oncology market's revenue are the rise in childhood obesity globally, the prevalence of childhood cancer, the increase in public awareness of cancer therapies, and increased R&D expenditure by pharmaceutical companies. Key Drivers, Restrains, and Opportunities of Global Pediatric Oncology Market The main drivers of the growth of the global market for pediatric oncology treatments are the rise in cancer prevalence, the attractive reimbursement environment, and health care reforms. According to WHO statistics from 2018, cancer is the primary cause of death for kids and teenagers worldwide; each year, almost 300,000 kids between the ages of 3 and 19 are given a cancer diagnosis. Additionally, the WHO established the Global Initiative for Youth Cancers in 2018 with a number of partners to offer effective childhood cancer programmes around the globe. WHO predicted that by the end of 2021, 4, 00,000 children and teenagers globally, aged 3 to 19 would receive a cancer diagnosis in each year. Additionally, in developed nations, there have been widespread introductions of programmes to raise awareness about pediatric cancer, and government investments to improve the pediatric healthcare system have increased. In turn, these variables will fuel market expansion in the ensuing years. The market is anticipated to grow quickly over the next years as more new medicines are released and more cutting-edge cancer treatments are created by pharmaceutical companies. Global Pediatric Oncology Market: Segmentation Based on indication, treatment, end-user, and location, the global market for pediatric oncology treatments can be divided. Leukaemia, bone tumours, brain malignancies, retinoblastoma, lymphoma, and other indications comprise the global market. The vast majority of childhood malignancies are leukaemia-related. Given that, it is the most prevalent cancer in children, the category is expected to dominate the market over the projection period. Chemotherapy, radiation, tumour surgery, and bone marrow transplantation are the different types of treatments available in the global pediatric oncology treatment market. Growing public awareness of cancer treatment options, investment in R&D, and an increase in the prevalence of children cancers like neuroblastoma are all factors - driving market expansion. According to research conducted by the National Cancer Institute in February 2022, there will be one case of neuroblastoma for every 7000 infants. In Each year, 10.54 out of every 1,000,000 children under the age of 15 are diagnosed with this disease. Global Pediatric Oncology Market- By Indication Leukaemia Bone Tumors Brain Cancers Retinoblastoma Global Pediatric Oncology Market- By Treatment Chemotherapy Radiotherapy Tumor Surgery Blood & Marrow Transplantation Global Pediatric Oncology Market- By End-user Hospitals Specialty Clinics Cancer & Radiation Therapy Centres Pediatric Oncology Treatment Market: Competitive Landscape Important Market Participants in the Pediatric Oncology Treatment Sector The existence of a significant number of prominent competitors leads to expansion of the pediatric oncology treatments globally and therefore, is extremely fragmented. The market for pediatric oncology treatments is projected to be driven by growth strategies used by major competitors. The following companies are major players in the global market for paediatric oncology treatments: St. Jude Children's Research Hospitals, Royal Children's Hospital Birmingham Children's and Women's Child Health and Development National Center The St. Louis Children's Hospitals and the Vanderbilt University Medical Center Health SSM and other notable participants Global Pediatric Oncology Market- By Region North America: U.S.A and Canada Europe: Germany, France, U.K., Italy Asia Pacific: China, Japan, India Latin America: Brazil, Mexico Middle East and Africa: South Africa, Rest of Middle East and Africa Contact: Andre Sarria | Program Manager Pediatric Cancer Congress 2023 WhatsApp No.: +44 7915648218 Email: pediatriconcology@meetingsemail.com

We are pleased to extend an invitation to you to attend the "World Congress on Diabetes and Pediatric Endocrinology" taking place in Paris, France on September 25-26, 2023. "New Insights and Clinical Advancements in Diabetic and Pediatric Endocrinology" is the focus of the next Conference. Pediatric Endocrinology 2023 is a premier venue for presenting research on diabetes management and therapies, fostering intellectual discourse on the topic, and advancing knowledge in the field for the good of society. It is the place where novel therapies and the disease's future management converge. About Conference The opportunity to network with eminent researchers, academics, scientific societies, therapists, counsellors, delegates, teachers, business professionals, and other executives who are authorities on endocrinology and diabetes is tremendous at Pediatric Endocrinology 2023. Welcome to Conference Series that continues its commitment to providing sincere and trustworthy contributions to the scientific community through its Open Access Initiative. Conference Series publishes 700+ open access journals with over 100,000 notable figures and renowned scientists on the editorial board and organizes 1000+ conferences annually across the USA, Europe, and Asia with the help of 1000 more scientific societies. The September 25-26, 2023, Paris, France, "World Congress on Diabetes and Pediatric Endocrinology" will feature symposiums, keynote addresses, plenary talks, poster sessions, and panel discussions on the most recent advancements in the study of diabetes and endocrine disorders. Students, faculty, deans, researchers, and leaders in the fields of diabetes and pediatric endocrinology can work together at this conference on issues relating to these conditions. The range of oral and poster presentations will provide attendees with opportunity to learn about endocrinology and diabetes research. Meet and socialize with nurses of all levels, from new graduates to deans, professors, and researchers. This is your finest chance to connect with the biggest group of attendees from the Pediatric Endocrinology 2023. Target Market: CEOs, Directors of Associations and Societies, Scientists, Doctors, Professors, Nurses, Diabetes Practitioners, Surgeons, Young Researchers, Industrial Delegates, Pharmaceutical Industries, Herbal Institutes, Herbal Research Centers, Healthcare Industries, Pharmacological and Pharmacognosy Industries, Nurses, Diabetes Practitioners, Medical Students, Surgeons, Young Researchers, Industrial Delegates. The Conference's goal is: To exchange their insights and research discoveries on all sides of metabolic syndromes and diabetes, it makes an effort to bring together top academics, researchers, medical professionals, and research scientists. Additionally, it offers a top multidisciplinary arena for academics, experts, medical professionals, and educators to discuss and share the most recent diabetes treatment methods. Abstract Qualification Standards Eligibility for authors: As the primary author, one person may submit up to two standard abstracts. An infinite number of abstracts for trials in progress may be submitted by individuals. A person may be a co-author on as many abstracts as they choose. Abstract Qualifications: Research on metabolic syndrome, endocrinology, medicine, and health are all welcome. Abstracts should include primary scientific data, describe clinical observations, or address scientific questions. Only if significant new information can be demonstrated, data from the long-term follow-up of previously published clinical trials may be submitted. A prospective randomized clinical trial's interim analysis will be taken into account if it is carried out according to the original protocol and is statistically sound. It is best to integrate the abstracts of themes that are clinically related. Note: If you submit more than one abstract for the same subject, you risk having one or more of them rejected. Conditions for Submission: Your full name, academic degree(s), institution, address, email address, and most current photo should all be provided. All upcoming communication from us on the position of your abstract will be sent to you. The conference proceedings will include the selected abstracts. Session & Track Track 1: Advanced Diabetes Treatment Technologies Track 2: Case Reports and Others Track 3: Chronic Complication of Diabetes Track 4: Children, Teens, and Adolescents with Thyroid Disorders Track 5: Clinical Diabetes Practice and Research Track 6: COVID-19 and diabetes Track 7: Diabetes Track 8: Diabetes Types Track 9: Diabetes Disease Disorder in Endocrinology Track 10: Diabetes Stem Cell Therapy Track 11: Diabetes with the Ketogenic Diet Track 12: Diabetes Genetics Track 13: Endocrine Diseases Treatment & Diagnosis Track 14: Emerging Diabetic Research Focus Track 15: Gestational Diabetes Track 16: Insulin Treatment Track 17: Nursing Diabetes Track 18: Ophthalmology and Diabetes Track 19: Pediatric Endocrinology Track 20: The Health Effects of Obesity Market Analysis Market size and analysis for endocrine disorders During the forecast period, the market for endocrine diseases is anticipated to increase significantly. Global geriatric, diabetes, and obesity rates are predicted to increase, which would help the market expand. Technology advancements, such as the creation of simple-to-use test kits, helped the uptake of user- and money-friendly home-based diagnostics. According to the International Federation, there will be 783 million adults with diabetes worldwide by 2045, up from the estimated 537 million in 2022. The acceptance of testing for the insulin hormone will rise as diabetes rates rise globally, which is expected to accelerate market expansion. During the projected period of 2022–2029, Data Bridge Market Research examines the growth rate of the global market for endocrine diseases. During the aforementioned forecast period, the global market for endocrine disorders is anticipated to grow at a CAGR of almost 7.4%. The market had a 2022 valuation of USD 10.28 billion and was expected to reach USD 18.2 billion by 2029. Along with information about market conditions like market value and growth rate, The market studies compiled by Data Bridge Market Research not only include segmentation, regional coverage, and main players, but also in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Dynamics of the Global Endocrine Disorders Market: Drivers Increasing Number of Parathyroid Conditions 200 million individuals worldwide suffer from thyroid disorders, primarily hyperthyroidism; in the majority of these nations, 50% of the population goes misdiagnosed. The elderly and women are more likely to have this illness. The global market for treating parathyroid illnesses is expected to rise as parathyroid diseases become more common. According to a recent study, Spain is expected to have had 12,903 individuals registered with parathyroid gland disorders and 13,897 admissions between 2003 and 2017. Primary hyperparathyroidism (pHPT), according to studies from Informa U.K. Limited, is the third most common endocrine condition. This accelerates market expansion. Increasing Oral Drug Demand Oral medications are predicted to accelerate market expansion. Given that the majority of medications are accessible in capsule and tablet form and that this is a very practical mode of administration, the category is anticipated to accelerate the global market. Opportunities Increasing Number of Seniors The older population is expected to grow, which would increase market size. Younger folks between the ages of 30 and 40 and elderly people are more likely to have parathyroid disorders. Therefore, a rise in the older population will probably present chances for the expansion of the global industry. According to an article in the Endocrine Society journal, a retrospective study from January 1997 to June 2018 estimated that 462 patients had been diagnosed with primary hyperparathyroidism, and 212 of them were above the age of 65. Research Activities Have Increased The market for treatments for parathyroid disorders is expected to be driven by key industry players' emphasis on R&D. For instance, in June 2017, Amgen, Inc. received a favorable recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the marketing authorization of Mimpara (cinacalcet), a pediatric formulation for secondary hyperparathyroidism in children aged three and older (HPT). As a result, these policies stimulate market expansion. Restraints/Challenges FDA Product Recall The Food and Drug Administration's (FDA) product recall has probably slowed the market's expansion for parathyroid disease treatments worldwide. For instance, the Takeda Pharmaceutical Company Limited announced the NATPARA U.S. recall in September 2019. The potential problem with rubber particles emerging from the rubber septum of the NATPARA cartridge is what prompted the recall. Limiting Hormone Therapy Adoption Oral medicines are typically regarded as the best treatment for hypoparathyroidism. This limits the use of hormone therapy that is currently accessible. Additionally, long-term positive medication usage symptoms have yet to be identified in clinical trials, which may restrict patient uptake of therapy. Therapy with rhPTH (1-84) is a long-term management option, although further long-term efficacy and safety evidence are required in people, according to the Drug Literature Review 2018. As a result, it limits market expansion. This report on the global endocrine disorders market details recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, and the effects of domestic and local market participants. It also analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, and product launches. Contact Data Bridge Market Research for an Analyst Brief to learn more about the global market for endocrine disorders. Our staff will assist you in making an informed choice to drive market expansion. Market Size for Endocrine Disorders Worldwide The global market for endocrine disorders is divided into segments based on end-user, distribution channel, drug class, method of administration, and treatment. The expansion of these divisions will enable you to study the industries' scarce growth segments and give users a comprehensive market overview and industry insights to aid in the identification of key market applications. Treatment Addison's illness Gigantism Cushing's Syndrome with Goiter ovarian polycystic syndrome (PCOS) Diabetes acromegaly Others Drug Class Estrogen Testosterone Progesterone Replacement Therapy Route of Administration Oral Parenteral End-Users Hospitals Homecare Speciality Centers Others Distribution Channel Hospital Pharmacy Online Pharmacy Retail Pharmacy Past conference Report Pediatric Endocrinology 2022 Report Conference Series hosting the event “2nd World Congress on Diabetes and Pediatric Endocrinology” at Paris, France during September 25-26, 2023. The conferences were organized with a focus on the themes“Scrutinizing Recent Trends in Diabetes and Endocrinology” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering. The event proceedings were carried out through several Scientific-sessions and plenary lectures, Conference Series would like to express a sincere thankfulness to all the Honorable guests and Keynote Speakers of 2nd World Congress on Diabetes and Pediatric Endocrinology. We would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Pediatric Endocrinology 2023. Pediatric Endocrinology 2023 committee would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers, Jason D. Gardner Louisiana State University Health Sciences Centre USA, Alexandra Lucas University of Florida USA, Helmy M. Siragy,, University of Virginia Health System USA, Masayoshi Yamaguchi,, Emory University USA, Heinrich Taegtmeyer,, University of Texas USA, have given a wonderful talk which makes allows the delegates and other attendees to gain the knowledge about main course of the event. Pediatric Endocrinology 2023 Organizing Committee would like to thank the Moderator of the conference Scrutinizing Recent Trends in Diabetes and Endocrinology, who contributed a lot for the smooth functioning of this event and for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support. Conference Series also took the privilege of Pediatric Endocrinology 2023 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success. We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events. We would also like to thank Chairs and Co-chairs of the conference, Luisa Mestroni,, University of Colorado USA, Mehran Roxana,, Mount Sinai University USA, Sarah X. Zhang,, State University of New York USA for a being a great support for our event to be a grand success. A series of lectures by distinguished professionals discussed the recent trends and issues in inter-disciplinary Paediatric Endocrinology and its technical advancements. Save your dates for the most awaited event of 2023 With a great response and feedback which we received from participants and supporters from Pediatric Endocrinology 2022, we are proud to announce our upcoming conferences in the Series 2nd World Congress on Diabetes and Pediatric Endocrinology in Paris, France with the theme of Scrutinizing Recent Trends in Diabetes and Endocrinology Some of our conference images are as follows: The main aim of this conference is to solicit the gracious presence of our honourable, to the upcoming conference “2nd World Congress on Diabetes and Pediatric Endocrinology” that is going to be held during September 25-26, 2023 in Paris, France, to share and exchange their knowledge. It is an International platform for business delegates, B2B meetings, poster presentations, workshops, symposia, networking and more. It will offer a platform wherein you can ensure enormous exposure and networking by exhibiting products and services. Grab the opportunities, and share your innovative ideas, new technologies and recent researches. Pediatric Endocrinology 2023 witnesses an amalgamation of peerless speakers who enlightened the gathering with their contribution towards the prevention of Paediatric related difficulties, its effects and treatment on Diabetes. For being a Experts Paediatric in and Diabetes, we hope that this platform gives knowledge and new updates by undergoing with the several interactive sessions to encourage the exchange of innovative ideas in the field of Rheumatology and its advancements, in that all the session talks are consider to be a great talks which makes the delegates, exhibitor, collaborators and other speakers feels so much interesting. Being a significant expert in this area we would like to Invite you as an International Organizing Committee Members, Speakers, Keynote speakers, Young Research forum, Sponsors and Exhibitor, etc. for Paediatric Endocrinology 2023 . Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Otology, Rhinology, and Laryngology and share the cross-cultural experiences of various principles and practices. The centre of the activity of Pediatric Endocrinology 2023 is to produce the clear visual definition by undergoing with Oral Presentation, Poster presentation, Workshop, Exhibition, networking and interacting session With the feedback from your renowned Speakers, we have added some of the new Session tracks that needs to be focused such as such as Advanced Diabetes Treatment Technologies, Case Reports and Others, Chronic Complication of Diabetes, Children, Teens, and Adolescents with Thyroid Disorders, Clinical Diabetes Practice and Research, With the great support we have successfully completed Pediatric Endocrinology 2023 and we are expecting huge response and support from the Diabetes and Pediatric Doctors, and Diabetes Pediatric Professionals, Young researchers, Students, Delegates, Directors and other Diabetes and Pediatric related companies to have your gracious presence at on Pediatric Endocrinology September 25-26, 2023 in Paris, France to make this congress a great successful event of the year 2023 Join our team Pediatric Endocrinology 2023 at this beautiful city of Paris, France and let’s make this professional gathering a Great success Contact us: Andre Sarria Program Manager Pediatric Endocrinology 2023 Website: https://pediatricendocrinology.conferenceseries.com/